Stents Market - Forecast(2021 - 2026)

Report Code: HCR 0693 Report Format: PDF + Excel (Delivery in 48 Hrs)

Stents Market Overview

Stents Market size is estimated to reach $15,790.2 million by 2026, growing at a CAGR of 5.2% during the forecast period 2021-2026. A stent is a short mesh tube that acts as a scaffold to help keep the artery open. It restores blood or other fluids, depending on where it is placed. Stent implants are commonly used to treat heart abnormalities such as blocked blood vessels. They are also inserted in the ureter to prevent obstruction of urine from the kidney, in the gall bladder to allow passage of bile in patients, in the abdomen & gastrointestinal tract among others. Stents are in great demand for diseases such as cardiovascular disease in elderly and middle-aged patients. The technological advancements in stents development also play a major role in market growth. The stents now are biodegradable as they completely disappear over time and decrease the risk associated with late stent thrombosis. The increasing prevalence of coronary artery diseases and peripheral artery diseases is estimated to boost the market growth over 2021-2026.

Stents Market Report Coverage

The report: “Stents Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Stents Market.
By Product Type: Coronary, Peripheral, Biliary, Carotid, Neurovascular, and others.
By Material: Metallic, Polymer, and Natural.
By Geography: Americas, Asia-Pacific, Europe, and Rest of World.

Key Takeaways

  • Geographically, the Americas region is poised to see extraordinary development owing to the minimally invasive surgeries and increasing the population of the people suffering from CVD that requires stenting procedures in the region.
  • Based on Product type, the Coronary segment is gaining demand owing to the high prevalence of cardiovascular diseases coupled with the growing technological advancements in coronary stents. 
  • The lack of large-scale availability of advanced surgical equipment and skilled personnel in underdeveloped economies and developing economies is estimated to restrain the market growth during the forecast period 2021-2026.
  • Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Stents Market report.

Stents Market Segment Analysis - By Product Type

The global Stents Market based on Product Type can be further segmented into Coronary, Peripheral, Biliary, Carotid, Neurovascular, and others. The Coronary Stent segment is the major segment generating revenue in 2020. This is owing to the high prevalence of cardiovascular diseases coupled with the growing technological advancements in coronary stents. The Carotid stent segment is estimated to register the fastest CAGR of 9.2% during the forecast period 2021-2026. This is owing to the rise in the prevalence of disorders such as ischemic stroke, peripheral vascular lesions leading the increasing demand of Carotid Stents in coming years.

Stents Market Segment Analysis - By Material

The global Stents Market based on Material can be further segmented into Metallic, Polymer, and Natural. The Metallic segment registers for the highest market share in 2020. This is owing to the increasing demand for metallic stents across the globe. In addition, they lower the risk of restenosis and the other complications. Moreover, usage of bioresorbable metal vascular stents is increasing owing to its presence of alloys that degrades safely within the body. The Polymer segment is estimated to register the fastest CAGR for the period 2021-2026. This is owing to its cost-effectiveness. Furthermore, the use of non-metallic long-term stents for ureteral obstruction is driving the demand.

Stents Market Segment Analysis - By Geography

The global Healthcare Regulatory Affairs Outsourcing Market based on Geography, can be further segmented into the Americas, Asia-Pacific, Europe, and Rest of World. Americas registered for the highest revenue share of 36.76% globally in 2020 owing to the minimally invasive surgeries and increasing the population of the people suffering from CVD and other high-risk factor requiring stenting procedures. In addition, technological advancements in stent technologies during the past three decades, such as bifurcated stents and the use of biodegradable materials, have further augmented market growth. However, Asia-Pacific is estimated to outpace all the regions by clocking the highest CAGR during the forecast period 2021-2026 owing to the increasing usage of vascular stents for cardiovascular diseases, the introduction of new and cost-effective stents by the key players in this region.

Stents Market Drivers

Development of Bioresorbable Vascular Scaffolds (BVS)

Traditional stents manufactured from metal mesh remain permanently in the body or unless removed through surgical intervention but bioresorbable vascular scaffolds are biodegradable, therefore, they completely disappear over time, additionally, and the risk of the restenosis using metallic stents and the drug-eluting stent has elevated the need for bioabsorbable stents thereby driving the market. BVS drug elution avoids non-intimal proliferation compared to drug-eluting stents, and complete bio-resorption is consistent with late vessel lumen enlargement, plaque regression, and vasomotion, owing to which BVS is set to boost the market growth during the forecast period 2021-2026.

Shorter Recovery Time as Compared to Open-Heart Surgery

The recovery time for Percutaneous Coronary Intervention (PCI) is significantly less than the by-pass surgeries. It takes only a few days to recover from stenting, whereas bypass surgery takes more than six weeks or even longer to recover from it, which is likely to fuel the market growth. PCI can be performed in a shorter interval of time than the by-pass surgery as the stent is inserted into the body from the groin area or arm through a catheter. Owing to the lesser recovery time and in-hospital time, the adoption of stents for cardiovascular diseases is set to grow at a healthy rate for the period 2021-2026.

Stents Market Challenges

Requirement of Advanced Surgical Equipment Along with Skilled Medical Personnel

The PCI technique requires skilled surgeons for the placement of the stent at the required location. Moreover, it also requires advanced devices such as atherectomy devices, Fractional Flow Reserve, Intravascular Ultrasound, Optical Coherence Tomography (OCT) Imaging, Near-Infrared Spectroscopy (NIRS) to transfer the stent to the target site. Thus, skilled medical personnel is required to operate the equipment and surgeons to perform the procedure. The lack of large-scale availability of such equipment and skilled personnel in underdeveloped economies and developing economies is set to hinder the market growth during the period 2020-2026.

Stents Market Industry outlook:

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Stents Market. Key companies of this market include Abbott Laboratories, B.Braun Melsungen AG, Boston Scientific, C.R Bard Incorporation, Cook Medical, Medtronic Plc, Biotronik, Elixir Medical Corporation, Stentys, and Terumo Medical Corporation. 

Acquisitions/Product Launches:

  • In July 2020, Biotronik has announced its next-generation balloon-expandable cobalt-chromium lilac stent system which is thinner, stronger and more flexible when compared to leading competitors. 
  • In June 2020, BD announced the acquisition of Straub Medical AG. This acquisition helped BD to enhance its product portfolio of stents.
  • In February 2019, Medtronic plc has the launch of the Valiant Navion thoracic stent graft system in Japan for the minimally invasive repair of thoracic descending aortic aneurysms (TAA) and complicated type B aortic dissections (TBAD).

For more Lifesciences and Healthcare Market reports - Please Click Here
1. Stents Market- Overview
    1.1 Definitions and Scope
2. Stents Market- Executive Summary
    2.1 Market Revenue, Market Size and Key Trends
    2.2 Key trends by Product Type
    2.3 Key trends by Geography
3. Stents Market – Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split by Key Companies 
    3.4 Patent Analysis – Key Companies
    3.5 Pricing Analysis
4. Stents Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Stents Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Stents Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes 
7. Stents Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Stents Market - By Product Type (Market Size - $Million/$Billion)
    8.1 Coronary 
    8.2 Peripheral 
    8.3 Biliary 
    8.4 Carotid 
    8.5 Neurovascular
    8.6 Others
9. Stents Market – By Material (Market Size – $Million/$Billion)
    9.1 Metallic
    9.2 Polymer
    9.3 Natural
10. Stents Market - By Geography (Market Size – $Million/$Billion)
    10.1 Americas
        10.1.1 U.S.
        10.1.2 Canada
        10.1.3 Mexico
        10.1.4 Brazil
        10.1.5 Rest of Americas
    10.2 Europe
        10.2.1 Germany
        10.2.2 France
        10.2.3 Italy
        10.2.4 Spain
        10.2.5 Russia
        10.2.6 U.K.
        10.2.7 Rest of Europe
    10.3 Asia-pacific
        10.3.1 China
        10.3.2 India
        10.3.3 Japan
        10.3.4 South Korea
        10.3.5 Rest of Asia-Pacific
    10.4 Rest of the World
        10.4.1 Middle East
        10.4.2 Africa
11. Stents Market - Entropy
12. Stents Market – Industry/Segment Competition Landscape Premium
    12.1 Market Share Analysis
        12.1.1 Global Market Share – Key Companies
        12.1.2 Market Share by Region – Key companies
        12.1.3 Market Share by Countries – Key Companies
        12.1.4 Best Practices for Companies
13. Stents Market– Key Company List by Country Premium Premium
14. Stents Market Company Analysis
    14.1 Abbott Laboratories 
    14.2 B.Braun Melsungen AG
    14.3 Boston Scientific 
    14.4 C.R Bard Incorporation
    14.5 Cook Medical
    14.6 Medtronic Plc
    14.7 Biotronik
    14.8 Elixir Medical Corporation 
    14.9 Stentys
    14.10 Terumo Medical Corporation 
"*Financials for private companies would be provided on a best efforts basis”.
List of Tables

Table 1 Product Benchmarking
Table 2 Stents Market Revenue, By Product Type, 2018-2024 ($M)
Table 3Global Stents Market Revenue, By Material, 2018-2024 ($M)
Table 4 Americas Stents Market Revenue, By Product, 2018-2024 ($M)
Table 5 Americas Stents Market Revenue, By Material, 2018-2024 ($M)
Table 6 Americas Stents Market Revenue, By Country, 2018-2024 ($M)
Table 7 Europe Stents Market Revenue, By Product, 2018-2024 ($M)
Table 8 Europe Stents Market Revenue, By Material, 2018-2024 ($M)
Table 9 Europe Stents Market Revenue, By Country, 2018-2024 ($M)
Table 10 Global Stents Market Revenue, By Region, 2018-2024 ($M)
Table 11 APAC Stents Market Revenue, By Product, 2018-2024 ($M)
Table 12 APAC Stents Market Revenue, By Material, 2018-2024 ($M)
Table 13 APAC Stents Market Revenue, By Country, 2018-2024 ($M)
Table 14 RoW Stents Market Revenue, By Region, 2018-2024 ($M)
Table 15 RoW Stents Market Revenue, By Product Type, 2018-2024 ($M)
Table 16 RoW Stents Market Revenue, By Material, 2018-2024 ($M)
     


List of Figures

Figure1 Stents Market – Segmentation
Figure2 Global Stents Market Value, 2018-2024 ($M)
Figure3 Global Stents Market Value Share, By Product Type, 2018 (%)
Figure4 Global Stents Market Value Share, By Material, 2018 (%)
Figure5 Global Stents Market Value Share, By Region, 2018 (%)
Figure6 Global Stents Market Value Share, By Key Players, 2018 (%)
Figure7 No. of Patents Granted, By Year, 2014-2019* 
Figure8 Share of Patents Granted, By Country, 2014-2019* (%)
Figure9 Share of Patents Granted, By Applicant, 2014-2019* (%)
Figure10 Boston Scientific Corporation, Financials, 2018 ($M)
Figure11 Abbott Laboratories, Financials, 2018 ($M) 
Figure12 Terumo Corp., Financials, 2018 ($M)
Figure13 Medtronic Plc, Financials, 2018 ($M)
Figure14 B.Braun Melsungen AG, Financials, 2018 ($M)
Figure15 Earning Per Share, By Company, 2018 ($M) 
Figure16 Share of U.S. Population Aged 20 and Above, By Disease Type, 2003-2018 (%)
Figure17 Coronary Stent Pricing Analysis, By Type, 2018-2024 ($)
Figure18 Stent Market Lifecycle, 2018-2024
Figure19 Deaths from Coronary Heart Disease Compared with Other Causes, 15-59 Years, 2018 (%)
Figure20 Deaths from Coronary Heart Disease Compared with Other Causes, 60 Years and above, 2018 (%)
Figure21 Stents Market Revenue, By Coronary Stent, 2018 -2024 ($M)
Figure22 Global Prevalence of PAD By Age Group (Years), 2018 (%)
Figure23 Stents Market Revenue, By Peripheral Stent, 2018 -2024 ($M)
Figure24 Global Carotid Artery Disease, 2018 (%)
Figure25 Stents Market Revenue, By Carotid Stent, 2018 -2024 ($M)
Figure26 Top 5 with Neurovascular Disease, 2018 (%)
Figure27 Stents Market Revenue, By Neurovascular Stent, 2018 -2024 ($M)
Figure28 New Cases of Pancreatic Cancer, By Age Group, 2018 (%)
Figure29 Stents Market Revenue, By Biliary Stent, 2018 -2024 ($M)
Figure30 Death Caused By Pancreatic Cancer, By Age Group, 2018 (%)
Figure31 Stents Market Revenue, By Other Stents, 2018 -2024 ($M)
Figure32 Stents Market Revenue, By Metallic, 2018-2024 ($M)
Figure33 Stents Market Revenue, By Polymer, 2018-2024 ($M)
Figure34 Stents Market Revenue, By Natural, 2018-2024 ($M)
Figure35 U.S.: Stents Market Revenue, 2018-2024 ($M)
Figure36 U.S.: New Cases of Cancer, 2018 (%)
Figure37 U.S.: Deaths Caused By Cancer, 2018 (%)
Figure38 Canada: New Cases of Cancer, 2018 (%)
Figure39 Canada: Stents Market Revenue, 2018-2024 ($M)
Figure40 Mexico: Stents Market Revenue, 2018-2024 ($M)
Figure41 Brazil: Stents Market Revenue, 2018-2024 ($M)
Figure42 Rest of Americas: Stents Market Revenue, 2018-2024 ($M)
Figure43 Germany: Stents Market Revenue, By Geography, 2018-2024 ($M)
Figure44 U.K: Stents Market Revenue, By Geography, 2018-2024 ($M)
Figure45 Italy: Stents Market Revenue, By Geography, 2018-2024 ($M)
Figure46 Spain: Stents Market Revenue, By Geography, 2018-2024 ($M)
Figure47 Russia: Stents Market Revenue, By Geography, 2018-2024 ($M)
Figure48 France: Stents Market Revenue, By Geography, 2018-2024 ($M)
Figure49 Rest of Europe: Stents Market Revenue, By Geography, 2018-2024 ($M)
Figure50 Chinese Population Age Structure, 2018 (%)
Figure51 China: Stents Market Revenue, By Geography, 2018-2024 ($M)
Figure52 Indian Population Age Structure, 2018 (%)
Figure53 India: Stents Market Revenue, By Geography, 2018-2024 ($M)
Figure54 Japan Obese Population Structure, 2014-2016 (%)
Figure55 Japan Historical Population Age Structure, 1975-2018* (%)
Figure56 Japan Total Health Expenditure ($M), 2014-2018
Figure57 Japan: Stents Market Revenue, By Geography, 2018-2024 ($M)
Figure58 South Korea Total Health Expenditure (% of GDP), 1995-2014
Figure59 South Korea: Stents Market Revenue, By Geography, 2018-2024 ($M)
Figure60 Rest of APAC: Stents Market Revenue, By Geography, 2018-2024 ($M)
Figure61 Middle East Adult Obesity Rate, 2018 (%)
Figure62 Middle East Stents Market Revenue, 2018—2024 ($M)
Figure63 Africa Stents Market Revenue, 2018—2024 ($M)